The Interferon-Induced Transmembrane Protein 3 -rs12252 Allele May Predict COVID-19 Severity Among Ethnic Minorities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Interferon-Induced Transmembrane Protein 3 -rs12252 Allele May Predict COVID-19 Severity Among Ethnic Minorities
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-09
DOI
10.3389/fgene.2021.692254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitigating ethnic disparities in covid-19 and beyond
- (2021) Mohammad S Razai et al. BMJ-British Medical Journal
- COVID-19 among American Indians and Alaska Natives
- (2021) Talha Burki LANCET INFECTIOUS DISEASES
- Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries
- (2021) Jiangmei Liu et al. BMJ-British Medical Journal
- The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19
- (2021) Kristina Schönfelder et al. CYTOKINE
- Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality
- (2021) Jahad Alghamdi et al. GENOMICS
- Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020–May 2021
- (2021) Prabasaj Paul et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019
- (2020) Yonghong Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- Hospitalization and Mortality among Black Patients and White Patients with Covid-19
- (2020) Eboni G. Price-Haywood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities
- (2020) Tony Kirby Lancet Respiratory Medicine
- Covid’s Color Line — Infectious Disease, Inequity, and Racial Justice
- (2020) Michele K. Evans NEW ENGLAND JOURNAL OF MEDICINE
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- (2020) David Ellinghaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells
- (2020) Mahmood Yaseen Hachim et al. Frontiers in Immunology
- The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19
- (2020) Juan Gómez et al. CYTOKINE
- Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
- (2020) Guoli Shi et al. EMBO JOURNAL
- IFITM3: How genetics influence influenza infection demographically
- (2019) Dannielle Wellington et al. Biomedical Journal
- Distribution of IFITM3 polymorphism (dbSNP: rs12252) in mestizo populations in four states of Mexico
- (2018) J. J. López-Jiménez et al. International Journal of Immunogenetics
- IFITM3 directly engages and shuttles incoming virus particles to lysosomes
- (2018) Jennifer S. Spence et al. Nature Chemical Biology
- Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses
- (2017) Xuesen Zhao et al. JOURNAL OF VIROLOGY
- Natural mutations in IFITM3 modulate post‐translational regulation and toggle antiviral specificity
- (2016) Alex A Compton et al. EMBO REPORTS
- The Legacy of Past Pandemics: Common Human Mutations That Protect against Infectious Disease
- (2016) Kelly J. Pittman et al. PLoS Pathogens
- IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
- (2014) Charles C. Bailey et al. Annual Review of Virology
- Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals
- (2013) Yong-Hong Zhang et al. Nature Communications
- IFITM3 restricts the morbidity and mortality associated with influenza
- (2012) Aaron R. Everitt et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now